Cost Effectiveness of Human Papillomavirus-16/18 Genotyping in Cervical Cancer Screening

被引：0
|
作者：
Warner K. Huh
Erin Williams
Joice Huang
Tommy Bramley
Nick Poulios
机构：
[1] University of Alabama at Birmingham,
[2] Xcenda,undefined
[3] Roche Molecular Diagnostics,undefined
来源：
Applied Health Economics and Health Policy | 2015年 / 13卷
关键词：
Cervical Cancer; Cervical Intraepithelial Neoplasia; Cervical Cancer Screening; Cervical Screening; Cervical Cancer Incidence;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：95 / 107
页数：12
相关论文
共 50 条
  • [41] Cost-effectiveness of human papillomavirus vaccination in Belgium: Do not forget about cervical cancer screening
    Thiry, Nancy
    De Laet, Chris
    Hulstaert, Frank
    Neyt, Mattias
    Huybrechts, Michel
    Cleemput, Irina
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2009, 25 (02) : 161 - 170
  • [42] Cost-effectiveness of human papillomavirus testing in cervical cancer screening. A review of decision analyses
    Siebert, U
    Sroczynski, G
    Marckmann, G
    Hillemanns, P
    GYNAKOLOGE, 2003, 36 (04): : 341 - 348
  • [43] Re: Cost-effectiveness of cervical cancer screening: cytology versus human papillomavirus DNA testing
    Chung, Soo-Ho
    Kim, Tae-Hee
    Lee, Hae-Hyeog
    Kim, Jun-Mo
    Kim, Yeon-Suk
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2016, 123 (08) : 1400 - 1401
  • [44] DETECTION OF HUMAN HERPESVIRUS-6 AND HUMAN PAPILLOMAVIRUS-16 IN CERVICAL-CARCINOMA
    CHEN, M
    WANG, H
    WOODWORTH, CD
    LUSSO, P
    BERNEMAN, Z
    KINGMA, D
    DELGADO, G
    DIPAOLO, JA
    AMERICAN JOURNAL OF PATHOLOGY, 1994, 145 (06): : 1509 - 1516
  • [45] Effectiveness of high-risk human papillomavirus genotyping for cervical cancer screening. A multicentre screening cohort study in rural China
    Yu, Yan-Qin
    Jiang, Ming-Yue
    Zhang, Xun
    Pan, Qin-Jing
    Dang, Le
    Feng, Rui-Mei
    Ali, Nasra Mohamoud
    Chen, Wen
    Qiao, You -Lin
    ANALES DEL SISTEMA SANITARIO DE NAVARRA, 2024, 47 (02)
  • [46] THE PRESENCE OF HUMAN PAPILLOMAVIRUS-16 GENOME IN THE CASKI CERVICAL-CARCINOMA DNA
    STUPAR, M
    IUGOSLAVICA PHYSIOLOGICA ET PHARMACOLOGICA ACTA, 1989, 25 (01) : 45 - 52
  • [47] THE PHYSICAL STATE OF HUMAN PAPILLOMAVIRUS-16 DNA IN CERVICAL-CARCINOMA AND CERVICAL INTRAEPITHELIAL NEOPLASIA
    FUKUSHIMA, M
    YAMAKAWA, Y
    SHIMANO, S
    HASHIMOTO, M
    SAWADA, Y
    FUJINAGA, K
    CANCER, 1990, 66 (10) : 2155 - 2161
  • [48] The Potential Cost-Effectiveness of Extended Genotyping in US Cervical Cancer Screening Paradigms
    Asjes, Caitlin
    Andrews, Jeff
    OBSTETRICS AND GYNECOLOGY, 2018, 131 : 188S - 188S
  • [49] A cost-effectiveness analysis of adding a human papillomavirus vaccine to the Australian National Cervical Cancer Screening Program
    Kulasingam, Shalini
    Connelly, Luke
    Conway, Elizabeth
    Flocking, Jane S.
    Myers, Evan
    Regan, David G.
    Roder, David
    Ross, Jayne
    Wain, Gerard
    SEXUAL HEALTH, 2007, 4 (03) : 165 - 175
  • [50] Cost-effectiveness analysis of liquid-based cytology and human papillomavirus testing in cervical cancer screening
    Bidus, Michael A.
    Maxwell, G. Larry
    Kulasingam, Shalini
    Rose, G. Scott
    Elkas, John C.
    Chernofsky, Mildred
    Myers, Evan R.
    OBSTETRICS AND GYNECOLOGY, 2006, 107 (05): : 997 - 1005
12345